Διαπανεπιστημιακό - Διατμηματικό ΠΜΣ Οργάνωση και Διοίκηση Υπηρεσιών Υγείας-Πληροφορική Υγείας
Library of the School of Health Sciences

2017-10-05

2017

Alexandratou Kyriaki-Spyridoula

Φιλντίσης Γεώργιος, Καθηγητής, Νοσηλευτική, ΕΚΠΑ
Τσουμάκας Κωνσταντίνος, Καθηγητής, Νοσηλευτική, ΕΚΠΑ
Διομήδους Μαριάννα, Αναπληρώτρια Καθηγήτρια, Νοσηλευτική, ΕΚΠΑ

Η χρήση των γενόσημων φαρμάκων στα συστήματα υγείας σε καιρό κρίσης

Greek

The Use of Generic Medicine to Health Systems in Time of Crisis

ABSTRACT
Background: Since 2008, many countries were confronted with the phenomenon of global economic crisis and its consequences in the fields of economy and society, and in the health sector. The increase in drugs’ consumption and public’s preference for expensive innovative drugs led to a subsequent rise of health expenditures, thus causing governments to turn their attention to the drug sector and more specifically to generic substitution. The introduction of generic medicines in national healthcare systems has been highly debated lately as an effective way to control and reduce pharmaceutical expenditures.
Aim: The aim of this study was to review developments in the introduction and use of generic medicine in international health systems in the period of recent economic crisis, analyzing the key market points and how it was affected by the implementation of economic austerity.
Method: The study was conducted through systematic literature review from 2007 to 2017 and the databases that were used were Pub Med, Google Scholar and websites of the Greek Ministry of Health, EL.STAT and OECD. Overall, 98 research studies have been found, from which 23 were selected. The selection criteria were: a) articles, which were primary studies, reviews or meta-analyses, b) articles available in full text, c) articles written in English or Greek and d) articles regarding people.
Results: The literature review shows that the introduction and use of generic medicines in international health systems during the economic crisis is a significant measure in reducing pharmaceutical expenditure, but also a low-cost means of healthcare provision. However, in several studies, doubt and suspicion by consumers
67
and health professionals were recorded, regarding the safety, efficacy and quality of generics.
Conclusion: As the need to control and reduce pharmaceutical expenditure is becoming increasingly urgent, governments all over the world are urged to develop policies promoting generics in parallel with maintaining the quality of healthcare and public health.
Key words: generic drug, generic medicine, health system, economic crisis

Health Sciences

Generic drug, Generic medicine, Health system, Economic crisis

No

0

Yes

143

67

File access is restricted only to the intranet of UoA.

https://pergamos.lib.uoa.gr/uoa/dl/object/1963800